Bullfrog AI (BFRG) Competitors $1.50 -0.01 (-0.33%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. ANRO, ACHL, RPTX, ASRT, CRVO, QNCX, RENB, VTGN, CNTB, and OTLKShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include Alto Neuroscience (ANRO), Achilles Therapeutics (ACHL), Repare Therapeutics (RPTX), Assertio (ASRT), CervoMed (CRVO), Quince Therapeutics (QNCX), Renovaro (RENB), VistaGen Therapeutics (VTGN), Connect Biopharma (CNTB), and Oncobiologics (OTLK). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Its Competitors Alto Neuroscience Achilles Therapeutics Repare Therapeutics Assertio CervoMed Quince Therapeutics Renovaro VistaGen Therapeutics Connect Biopharma Oncobiologics Alto Neuroscience (NYSE:ANRO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment. Do analysts prefer ANRO or BFRG? Alto Neuroscience currently has a consensus target price of $8.50, indicating a potential upside of 277.78%. Given Alto Neuroscience's stronger consensus rating and higher probable upside, equities analysts plainly believe Alto Neuroscience is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alto Neuroscience 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher earnings & valuation, ANRO or BFRG? Bullfrog AI has higher revenue and earnings than Alto Neuroscience. Bullfrog AI is trading at a lower price-to-earnings ratio than Alto Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlto NeuroscienceN/AN/A-$61.43M-$2.34-0.96Bullfrog AI$60K236.29-$6.99M-$0.81-1.86 Which has more volatility & risk, ANRO or BFRG? Alto Neuroscience has a beta of 1.93, meaning that its stock price is 93% more volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Does the media favor ANRO or BFRG? In the previous week, Alto Neuroscience had 5 more articles in the media than Bullfrog AI. MarketBeat recorded 8 mentions for Alto Neuroscience and 3 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 1.00 beat Alto Neuroscience's score of 0.28 indicating that Bullfrog AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alto Neuroscience 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bullfrog AI 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in ANRO or BFRG? 1.0% of Bullfrog AI shares are held by institutional investors. 33.9% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is ANRO or BFRG more profitable? Alto Neuroscience's return on equity of -39.35% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Alto NeuroscienceN/A -39.35% -33.86% Bullfrog AI N/A -163.23%-139.94% SummaryAlto Neuroscience beats Bullfrog AI on 8 of the 14 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.18M$2.02B$5.47B$8.89BDividend YieldN/AN/A5.36%4.13%P/E Ratio-1.8638.9326.4119.70Price / Sales236.2915.24406.20108.23Price / CashN/A56.2225.8827.49Price / Book2.648.917.895.39Net Income-$6.99M-$63.71M$3.15B$248.34M7 Day Performance-5.94%-0.68%0.54%0.65%1 Month Performance-10.49%2.52%4.77%4.80%1 Year Performance-10.95%4.01%32.14%17.53% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI1.2317 of 5 stars$1.51-0.3%N/A-12.7%$14.18M$60K-1.864ANROAlto Neuroscience2.6651 of 5 stars$2.37+5.1%$8.50+259.4%-79.3%$60.91MN/A-1.01N/ANews CoverageACHLAchilles TherapeuticsN/A$1.48flatN/AN/A$60.83MN/A-0.90250RPTXRepare Therapeutics2.7039 of 5 stars$1.41flat$4.50+219.1%-57.9%$60.48M$53.48M-0.47180News CoverageASRTAssertio1.7596 of 5 stars$0.63+0.3%$2.75+335.7%-48.3%$60.26M$124.96M-1.9720News CoverageCRVOCervoMed3.2163 of 5 stars$6.52-4.8%$27.63+323.7%-63.3%$59.61M$9.74M-2.994Positive NewsQNCXQuince Therapeutics3.2869 of 5 stars$1.32+1.5%$8.00+506.1%+120.0%$59.11MN/A-0.9560RENBRenovaro1.2471 of 5 stars$0.37+7.9%N/A-83.5%$58.76MN/A-0.4820News CoverageGap UpHigh Trading VolumeVTGNVistaGen Therapeutics1.7563 of 5 stars$1.96-2.0%N/A-42.5%$58.31M$490K-1.1840CNTBConnect Biopharma3.7869 of 5 stars$0.98-5.3%$7.00+617.9%-35.5%$57.23M$26.03M0.00110OTLKOncobiologics2.4141 of 5 stars$1.68-1.5%$9.60+471.4%-78.3%$57.23MN/A-1.8520Positive NewsGap Up Related Companies and Tools Related Companies Alto Neuroscience Competitors Achilles Therapeutics Competitors Repare Therapeutics Competitors Assertio Competitors CervoMed Competitors Quince Therapeutics Competitors Renovaro Competitors VistaGen Therapeutics Competitors Connect Biopharma Competitors Oncobiologics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
